| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-51 |
| Equity
Latest Equity |
38.21 |
| Face Value
Latest Face Value |
1 |
| Reserves
Total Reserve |
483.5 |
| Dividend
Full Year Dividend % |
10 |
| Sales Turnover
Full Year Net Sales |
477.83 |
| Net Profit
Full Year Net Profit |
33.93 |
| Full Year CPS
Full Year Cash Per Share |
1.3 |
| Earning Per Share
Full Year Earning Per Share |
0.9 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
121.27 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
13.7 |
| Networth
Full Year Return on Networth |
5.86 |
| Price/Book Value
Price to Book value |
2.043796 |
| Yearly PE ratio
Full Year Price to Earning per share |
31.5 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
20.8 |
| Bse value
BSE Value in lakhs |
27.01 |
| Nse value
NSE Value in lakhs |
215.45 |
| High
52 week high |
41 |
| Low
52 week low |
17 |
| Price
NSE Current market price |
28 |
| CPM
Current market price |
28 |
| Market cap
BSE / NSE Market Cap |
1051.97 |
| Net profit
Latest Quarter Net Profit |
6.76 |
| Net profit variance
Latest Quarter Net Profit variance |
-67 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
435.69 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
74.38 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
17.07 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
40.66 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
8.64 |
| TTM NP
Trailing Twelve 12 month Net Profit |
66.1 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
-70.79 |
| TTM EPS
Trailing Twelve 12 month EPS |
0.59 |
| TTM PE
Trailing Twelve 12 month PE |
46.66 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
12.68 |
| Equity
Latest Equity |
38.21 |
| LTP
Latest Price (BSE/NSE) |
28 |
| Gross block
Latest Gross Block |
396.16 |
| Loans
Total loans |
34.15 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
11.2 |
| Year GPM
Full Year Gross Profit Margin |
10.1 |
| Quarter OPM
Latest quater Operation Profit Margin |
13.6 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 |
| YOY Sales Growth % | 26% | 26% | 23% | 34% | -12% | -16% | -5% | -5% |
| Gross Sales | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 |
| + Expenses | 108 | 106 | 100 | 225 | 103 | 112 | 107 | 105 |
| Material Cost % | 50% | 42% | 68% | 49% | 32% | 41% | 29% | 48% |
| Raw Material Cost | 64 | 60 | 70 | 62 | 43 | 54 | 42 | 55 |
| Change in Inventory | -2 | -1 | 17 | 2 | -7 | -6 | -7 | 3 |
| Manufacturing Cost % | 19% | 16% | 17% | 111% | 19% | 16% | 15% | 15% |
| Employee Cost % | 15% | 14% | 21% | 15% | 20% | 24% | 24% | 23% |
| Other Cost % | 3% | 4% | -28% | -0% | 23% | 15% | 20% | -0% |
| Raw Materials % | 52% | 43% | 54% | 48% | 38% | 46% | 34% | 45% |
| Purchase of Finished Goods % | -0% | 3% | -1% | 2% | 9% | 5% | 9% | 5% |
| Stock Adjustments % | 1% | 1% | -13% | -1% | 7% | 5% | 6% | -3% |
| Other Manufacturing Expenses % | 19% | 16% | 17% | 111% | 19% | 16% | 15% | 15% |
| Operating Profit | 17 | 33 | 29 | -97 | 8 | 5 | 15 | 17 |
| OPM % | 14% | 24% | 22% | -76% | 7% | 4% | 13% | 14% |
| + Other Income | 15 | 2 | 2 | 4 | 7 | 0 | 1 | 1 |
| Miscellaneous Income | 15 | 2 | 2 | 4 | 7 | 0 | 1 | 1 |
| Exceptional Income | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 |
| Interest | 2 | 4 | 3 | 3 | 3 | 3 | 4 | 3 |
| Depreciation | 3 | 5 | 5 | 5 | 4 | 4 | 5 | 4 |
| Profit before tax | 27 | 27 | 23 | -101 | 7 | -2 | 8 | 10 |
| + Tax % | 21% | 23% | 29% | 0% | -42% | 99% | 1% | 19% |
| Current Tax | 4 | 4 | 4 | 0 | 0 | 0 | 1 | 3 |
| Deferred Tax | 2 | 2 | 2 | 0 | -4 | -2 | -1 | -1 |
| + Net Profit | 21 | 21 | 16 | -101 | 11 | 0 | 8 | 8 |
| Extraordinary Income / Expense | 0 | 0 | 0 | -121 | 5 | -1 | -1 | 0 |
| Exceptional Item | 0 | 0 | 0 | -121 | 5 | -1 | -1 | 0 |
| Minority Interest (After Tax) | 1 | 1 | -3 | 1 | 0 | 0 | 0 | -1 |
| Net Profit After Minority Interest | 22 | 21 | 13 | -100 | 11 | 0 | 8 | 7 |
| EPS in Rs | 0.66 | 0.65 | 0.39 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 86 | 101 | 129 | 139 | 193 | 250 | 302 | 399 | 488 | 478 |
| Sales Growth % | 17% | 28% | 8% | 39% | 30% | 21% | 32% | 22% | -2% | |
| Gross Sales | 193 | 250 | 302 | 399 | 488 | 478 | ||||
| Excise Duty | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 73 | 93 | 110 | 118 | 154 | 197 | 243 | 322 | 388 | 542 |
| Material Cost % | 45% | 58% | 52% | 52% | 52% | 47% | 46% | 49% | 45% | 52% |
| Raw Material Cost | 39 | 61 | 70 | 74 | 98 | 123 | 142 | 200 | 238 | 229 |
| Change in Inventory | -1 | -2 | -3 | -2 | 3 | -5 | -4 | -5 | -16 | 19 |
| Manufacturing Cost % | 14% | 11% | 10% | 11% | 9% | 8% | 8% | 8% | 4% | 5% |
| Employee Cost % | 14% | 8% | 8% | 8% | 7% | 7% | 11% | 13% | 18% | 21% |
| Other Cost % | 12% | 15% | 15% | 14% | 11% | 17% | 16% | 11% | 12% | 36% |
| Raw Materials % | 46% | 60% | 54% | 53% | 51% | 49% | 47% | 50% | 49% | 48% |
| Purchase of Finished Goods % | 0% | 0% | 0% | 10% | 1% | 6% | ||||
| Stock Adjustments % | 1% | 2% | 3% | 1% | -1% | 2% | 1% | 1% | 3% | -4% |
| Power & Fuel % | 3% | 4% | 3% | 3% | 2% | 2% | 2% | 3% | 3% | 3% |
| Other Manufacturing Expenses % | 11% | 8% | 7% | 8% | 7% | 6% | 6% | 5% | 1% | 2% |
| Selling & Administration % | 10% | 10% | 9% | 11% | 11% | 16% | 15% | 11% | 11% | 10% |
| Miscellaneous Expenses % | 1% | 1% | 0% | 0% | 0% | 0% | 1% | 0% | 1% | 25% |
| Operating Profit | 13 | 8 | 19 | 21 | 39 | 53 | 59 | 77 | 100 | -64 |
| OPM % | 15% | 8% | 15% | 15% | 20% | 21% | 19% | 19% | 20% | -13% |
| + Other Income | 1 | 3 | 4 | 5 | 3 | 3 | 7 | 12 | 21 | 8 |
| Miscellaneous Income | 3 | 3 | 7 | 12 | 21 | 13 | ||||
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 5 | ||||
| Interest | 4 | 4 | 3 | 2 | 1 | 1 | 4 | 8 | 12 | 14 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 16 | 18 |
| Profit before tax | 38 | 52 | 54 | 70 | 92 | -88 | ||||
| + Tax % | 21% | 22% | 20% | 18% | 24% | 6% | ||||
| Current Tax | 1 | 3 | 5 | 5 | 7 | 11 | 11 | 12 | 15 | 2 |
| Deferred Tax | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 7 | -7 |
| + Net Profit | 30 | 40 | 44 | 57 | 70 | -83 | ||||
| Profit Growth % | 32% | 9% | 32% | 23% | -218% | |||||
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | -118 | ||||
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | -118 | ||||
| Minority Interest (After Tax) | 0 | 0 | 0 | 0 | 0 | 0 | -44 | 0 | -1 | 1 |
| Net Profit After Minority Interest | 0 | 7 | 19 | 20 | 30 | 40 | 0 | 57 | 70 | -82 |
| EPS in Rs | 22.53 | 61.87 | 26.44 | 39.39 | 13.02 | 14.16 | 1.74 | 1.84 | -2.17 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 | 38 |
| Reserves | 17 | 23 | 42 | 57 | 87 | 197 | 238 | 339 | 563 | 484 |
| + Borrowings | 28 | 30 | 25 | 30 | 21 | 35 | 68 | 151 | 142 | 162 |
| Secured Borrowings | 4 | 30 | 25 | 28 | 21 | 35 | 41 | 119 | 110 | 128 |
| Unsecured Borrowings | 24 | 0 | 0 | 2 | 0 | 0 | 27 | 33 | 32 | 34 |
| Deferred Credit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0 | 0 |
| + Other Liabilities | 12 | 16 | 21 | 14 | 18 | 24 | 37 | 172 | 103 | 157 |
| Current Liabilities | 12 | 15 | 21 | 13 | 18 | 23 | 36 | 100 | 88 | 147 |
| Provisions | 1 | 2 | 4 | 0 | 1 | 1 | 0 | 2 | 3 | 2 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 12 | 7 |
| Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 0 | 0 |
| Other liability items | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Total Liabilities | 60 | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
| + Fixed Assets | 23 | 26 | 29 | 32 | 38 | 53 | 122 | 254 | 370 | 325 |
| Gross Block | 23 | 33 | 37 | 42 | 51 | 69 | 145 | 305 | 437 | 396 |
| Accumulated Depreciation | 0 | 7 | 9 | 10 | 13 | 16 | 22 | 51 | 67 | 71 |
| CWIP | 1 | 1 | 2 | 3 | 4 | 10 | 35 | 97 | 9 | 31 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Other Assets | 36 | 46 | 61 | 74 | 92 | 224 | 216 | 342 | 467 | 485 |
| Inventories | 14 | 16 | 23 | 28 | 21 | 30 | 47 | 71 | 94 | 74 |
| Trade receivables | 13 | 21 | 25 | 28 | 36 | 60 | 80 | 150 | 184 | 224 |
| Cash Equivalents | 3 | 3 | 2 | 11 | 18 | 69 | 33 | 57 | 72 | 26 |
| Loans n Advances | 4 | 5 | 10 | 6 | 12 | 20 | 18 | 35 | 44 | 66 |
| Other asset items | 1 | 1 | 1 | 2 | 4 | 44 | 39 | 29 | 73 | 96 |
| Total Assets | 60 | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 9 | 8 | 14 | 12 | 30 | 6 | 29 | 13 | 27 | -43 |
| Profit from Operations | 15 | 30 | 29 | 42 | 54 | 62 | 79 | 104 | -58 | |
| Working Capital Changes | -4 | -10 | -12 | -6 | -37 | -20 | -57 | -63 | 25 | |
| Profit Before Tax & Extraordinary Items | 4 | 10 | 25 | 25 | 38 | 52 | 54 | 70 | 92 | -88 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 16 | 18 |
| Interest (Net) | 4 | 4 | 3 | 2 | 1 | 0 | 1 | 4 | 8 | 9 |
| Dividend Received | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Profit / Loss in Forex | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 3 |
| Receivables | 0 | -7 | -4 | -3 | -8 | -24 | -20 | -65 | -34 | -41 |
| Inventories | -2 | -2 | -7 | -5 | 7 | -9 | -16 | -4 | -24 | 21 |
| Trade Payables | -3 | 0 | 0 | -2 | 1 | 3 | 10 | 24 | -12 | 23 |
| Loans & Advances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Borrowing | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Direct Taxes Paid | -2 | -3 | -5 | -5 | -7 | -12 | -13 | -9 | -14 | -10 |
| + Cash from Investing Activity | -2 | -4 | -6 | -7 | -11 | -63 | -92 | -161 | -93 | -5 |
| Purchase of Fixed Assets | -2 | -4 | -6 | -6 | -9 | -24 | -101 | -85 | -43 | -45 |
| Sale of Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -87 | -7 | 0 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Received | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 4 | 5 | 5 |
| Dividend Received | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 1 | 0 | -1 | -2 | -39 | 6 | 7 | -47 | -16 |
| + Cash from Financing Activity | -6 | -5 | -9 | 3 | -11 | 108 | 26 | 172 | 81 | 2 |
| Proceeds from Issue of Shares | 0 | 0 | 0 | 0 | 0 | 96 | 0 | 0 | 0 | 0 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 27 | 32 | 0 | 3 |
| Proceeds from Short-Term Borrowings | 0 | 0 | 0 | 5 | 0 | 15 | 6 | 48 | 26 | 18 |
| Repayment of Long-Term Borrowings | -2 | -1 | -2 | 0 | 0 | -1 | 0 | 0 | -34 | 0 |
| Repayment of Short-Term Borrowings | 0 | 0 | -3 | 0 | -9 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 |
| Dividend Paid | 0 | 0 | 0 | 0 | -1 | -2 | -3 | -3 | -3 | -4 |
| Interest Paid | -4 | -3 | -2 | -1 | -1 | -4 | -8 | -12 | -14 | |
| Others | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 106 | 106 | 0 |
| Net Cash Flow | 1 | -1 | 0 | 8 | 7 | 51 | -37 | 24 | 15 | -46 |